What is OKYO Pharma Ltd ADR (OKYO) stock price today?

OKYO Pharma Ltd ADR (OKYO) currently trades at $1.56 per share. The stock has a market capitalization of $82.92M and a P/E ratio of —x.

Is OKYO stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, OKYO Pharma Ltd ADR has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -62.62.

Is OKYO Pharma Ltd ADR financially healthy?

OKYO Pharma Ltd ADR's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -62.62 places it in the distress.

OKYO

OKYO Pharma Ltd ADR

NASDAQ: OKYO · HEALTHCARE · BIOTECHNOLOGY

$1.56

+2.63% today

Updated 2026-04-30

Market cap

$82.92M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.11

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

Market cap

$82.92M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.11

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

4.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-62.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$8.00

+412.82%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity -0.05x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -62.62 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.53M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	—
Net income	$-5.43M	$-13.27M	$-16.83M	$-4.71M	$-2.59M
EPS	—	—	—	—	$-0.11
Free cash flow	$-5.47M	$-7.70M	$-9.49M	$-1.81M	$-1.53M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
OKYO	$82.92M	16	4.3	3.0	5.0	4.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

OKYO Pharma Ltd ADR trades at $1.56. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -62.62, it sits in the distress.

Frequently asked questions

What is OKYO Pharma Ltd ADR's stock price?

OKYO Pharma Ltd ADR (OKYO) trades at $1.56.

Is OKYO Pharma Ltd ADR overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of OKYO Pharma Ltd ADR (OKYO)?

The analyst target price is $8.00, representing +412.8% upside from the current price of $1.56.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-62.62 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

okyopharma.com

Quick metrics

P/S ratio—

ROE-2,969.00%

Beta-0.12

50D MA$1.64

200D MA$2.15

Shares out0.05B

Float0.02B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

OKYO vs LLY →OKYO vs JNJ →OKYO vs ABBV →Stock screener →